Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | ACHE | P22303 | 2/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.40 |
| ▸ | BCHE | P06276 | 1/20 | 0.40 |
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | CNR2 | P34972 | 4/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29285347 | 0.92 | LMNA (0.40) | HTTCYP2C19LMNAPOLBACHE | |
| SCHEMBL13932518 | 0.90 | IDO1 (0.41) | ACHECYP1A2CA9ALDH1A1TDP1 | |
| SCHEMBL30047777 | 0.85 | CALM1 (0.39) | POLBCYP3A4ALOX12TSHRSMN1; SMN2 | |
| SCHEMBL28906945 | 0.85 | CALM1 (0.39) | POLBCYP3A4ALOX12TSHRSMN1; SMN2 | |
| SCHEMBL779948 | 0.85 | CALM1 (0.39) | POLBCYP3A4ALOX12TSHRSMN1; SMN2 | |
| SCHEMBL30047680 | 0.85 | CALM1 (0.39) | POLBCYP3A4ALOX12TSHRSMN1; SMN2 | |
| SCHEMBL7063604 | 0.81 | L3MBTL1 (0.41) | HTTCYP2C19LMNAPOLBACHE | |
| SCHEMBL28468805 | 0.80 | SIGMAR1 (0.41) | HTTACHEL3MBTL1BCHECYP1A2 | |
| SCHEMBL28472082 | 0.80 | ALDH1A1 (0.39) | ACHEL3MBTL1BCHETSHRCNR2 | |
| SCHEMBL28462077 | 0.80 | PLA2G1B (0.42) | ACHECNR2ALDH1A1KDM4ERAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118580164-A | Preparation method of sulfoxide derivative | 华侨大学 | 2024-09-03 | — | — | CN | claimed |
| CN-118580164-A | Preparation method of sulfoxide derivative | 华侨大学 | 2024-09-03 | — | — | CN | disclosed |
| CN-118307453-A | Synthesis method of alkylaryl sulfoxide | 南京工业大学 | 2024-07-09 | — | — | CN | disclosed |
| WO-2021127337-A1 | TRPML MODULATORS | CASMA THERAPEUTICS, INC. (US) | 2021-06-24 | — | — | WO | disclosed |
| CN-109485587-B | Method for preparing sulfoxide compound by one-step reaction of benzyl chloride compound and thiophenol under metal-free condition | 陕西师范大学 | 2020-10-16 | — | — | CN | disclosed |
| CN-110041236-A | The synthetic method of thio-ether type compounds | 天津师范大学 | 2019-07-23 | — | — | CN | disclosed |
| EP-2399584-A1 | Boronic acids and esters as inhibitors of fatty acid amide hydrolase | Infinity Pharmaceuticals, Inc. (US) | 2011-12-28 | — | — | EP | disclosed |
| EP-2073816-B1 | BORONIC ACIDS AND ESTERS AS INHIBITORS OF FATTY ACID AMIDE HYDROLASE | INFINITY PHARMACEUTICALS INC (US) | 2011-09-14 | — | — | EP | disclosed |
| US-20100069381-A1 | GSK-3BETAINHIBITOR | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2010-03-18 | — | — | US | disclosed |
| US-6727294-B2 | RADIATION TRANSPARENT MOLDING MATERIALS | MITSUBISHI ENGINEERING-PLASTICS CORPORATION (JP) | 2004-04-27 | — | — | US | disclosed |
| US-20010034419-A1 | Radiation transparent molding materials | MITSUBISHI ENGINEERING-PLASTICS CORPORATION (JP) | 2001-10-25 | — | — | US | disclosed |
| US-4656290-A | Process for preparing thio, dithio or carbonyl compounds | CHINOIN GYOGYSZER ES VEGYESZETI TERMEKEK GYARA RT. (HU) | 1987-04-07 | — | — | US | disclosed |
| EP-0150026-A2 | Chemical process | CHINOIN Gyogyszer és Vegyészeti Termékek Gyára RT. (HU) | 1985-07-31 | — | — | EP | disclosed |
| US-4403054-A | SULFOXIDE COMPOUND OR SULFINYL-CONTAINING POLYMER | GENERAL ELECTRIC COMPANY (US) | 1983-09-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100069381-A1 | GSK-3BETAINHIBITOR | GSK3B, GSK3A, GSKIP | HTT 3480/4885CYP2C19 854/4885LMNA 1441/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.